Halozyme Therapeutics, Inc. (HALO)

71.48 -0.23 (-0.32%) USD  |  NASDAQ  |  Jan 22, 13:39
More

Halozyme Therapeutics Amortization Expense CF (Quarterly)

Amortization Expense CF (Quarterly) Chart

View Amortization Expense CF (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (Quarterly) Range, Past 5 Years

View Amortization Expense CF (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (Quarterly) Benchmarks

View Amortization Expense CF (Quarterly) Benchmarks
Start Trial
Johnson & Johnson --
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. --